261 related articles for article (PubMed ID: 12611639)
21. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling.
Mood K; Saucier C; Ishimura A; Bong YS; Lee HS; Park M; Daar IO
J Cell Physiol; 2006 Apr; 207(1):271-85. PubMed ID: 16331688
[TBL] [Abstract][Full Text] [Related]
24. The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy.
Warshamana-Greene GS; Litz J; Buchdunger E; García-Echeverría C; Hofmann F; Krystal GW
Clin Cancer Res; 2005 Feb; 11(4):1563-71. PubMed ID: 15746061
[TBL] [Abstract][Full Text] [Related]
25. Fibronectin enhances viability and alters cytoskeletal functions (with effects on the phosphatidylinositol 3-kinase pathway) in small cell lung cancer.
Kijima T; Maulik G; Ma PC; Madhiwala P; Schaefer E; Salgia R
J Cell Mol Med; 2003; 7(2):157-64. PubMed ID: 12927054
[TBL] [Abstract][Full Text] [Related]
26. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth.
Trusolino L; Bertotti A; Comoglio PM
Cell; 2001 Nov; 107(5):643-54. PubMed ID: 11733063
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343
[TBL] [Abstract][Full Text] [Related]
28. Targeting of mitogen-activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Li RC; Gherardi E; Zhao G; Watson N; Sasisekharan R; Fan TP
Circulation; 2003 Jun; 107(23):2955-61. PubMed ID: 12782568
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
[TBL] [Abstract][Full Text] [Related]
30. The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes.
Aasrum M; Ødegård J; Sandnes D; Christoffersen T
Biochim Biophys Acta; 2013 Dec; 1833(12):3286-3294. PubMed ID: 24126105
[TBL] [Abstract][Full Text] [Related]
31. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor.
Hayashi H; Ichihara M; Iwashita T; Murakami H; Shimono Y; Kawai K; Kurokawa K; Murakumo Y; Imai T; Funahashi H; Nakao A; Takahashi M
Oncogene; 2000 Sep; 19(39):4469-75. PubMed ID: 11002419
[TBL] [Abstract][Full Text] [Related]
32. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway.
Huang Q; Shen HM; Ong CN
Cell Mol Life Sci; 2005 May; 62(10):1167-75. PubMed ID: 15928809
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling.
Wang K; Zhuang Y; Liu C; Li Y
Arch Biochem Biophys; 2012 Oct; 526(1):38-43. PubMed ID: 22820099
[TBL] [Abstract][Full Text] [Related]
35. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.
Gupta AK; McKenna WG; Weber CN; Feldman MD; Goldsmith JD; Mick R; Machtay M; Rosenthal DI; Bakanauskas VJ; Cerniglia GJ; Bernhard EJ; Weber RS; Muschel RJ
Clin Cancer Res; 2002 Mar; 8(3):885-92. PubMed ID: 11895923
[TBL] [Abstract][Full Text] [Related]
36. Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway.
Okano J; Shiota G; Matsumoto K; Yasui S; Kurimasa A; Hisatome I; Steinberg P; Murawaki Y
Biochem Biophys Res Commun; 2003 Sep; 309(2):298-304. PubMed ID: 12951049
[TBL] [Abstract][Full Text] [Related]
37. LY294002-geldanamycin heterodimers as selective inhibitors of the PI3K and PI3K-related family.
Chiosis G; Rosen N; Sepp-Lorenzino L
Bioorg Med Chem Lett; 2001 Apr; 11(7):909-13. PubMed ID: 11294389
[TBL] [Abstract][Full Text] [Related]
38. Surfactant protein A regulates pulmonary surfactant secretion via activation of phosphatidylinositol 3-kinase in type II alveolar cells.
White MK; Strayer DS
Exp Cell Res; 2000 Feb; 255(1):67-76. PubMed ID: 10666335
[TBL] [Abstract][Full Text] [Related]
39. Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways.
Yue W; Wang JP; Conaway MR; Li Y; Santen RJ
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):265-74. PubMed ID: 14623520
[TBL] [Abstract][Full Text] [Related]
40. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway.
Yu XS; Du J; Fan YJ; Liu FJ; Cao LL; Liang N; Xu DG; Zhang JD
Oncotarget; 2016 Nov; 7(47):76827-76839. PubMed ID: 27765907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
